ProCE Banner Activity

Cancer Stem Cell–Targeting Agents for Gastrointestinal Cancers: Where Do We Stand in 2018?

Clinical Thought
Here’s my take on recent developments in cancer stem cell inhibitors for gastrointestinal cancers, including new data from ASCO 2018.

Released: June 28, 2018

Expiration: June 27, 2019

No longer available for credit.

Share

Faculty

Manish A. Shah

Manish A. Shah, MD

Assistant Member, Department of Medicine, Gastrointestinal Oncology
Memorial Sloan-Kettering Cancer Center
Attending Physician, Department of Medicine, Division of Solidy Tumor Oncology
Memorial Hospital
New York, New York

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by an educational grant from

Boston Biomedical

Faculty Disclosure

Primary Author

Manish A. Shah, MD

Assistant Member, Department of Medicine, Gastrointestinal Oncology
Memorial Sloan-Kettering Cancer Center
Attending Physician, Department of Medicine, Division of Solidy Tumor Oncology
Memorial Hospital
New York, New York

Manish A. Shah, MD, FASCO, has disclosed that he has received funds for research support from Boston Biomedical and Roche.